E004 (Epinephrine Inhalation Aerosol) HFA-MDI
API-E004-CL-D
Phase 3 small_molecule completed
Quick answer
E004 (Epinephrine Inhalation Aerosol) HFA-MDI for Asthma is a Phase 3 program (small_molecule) at Amphastar Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amphastar Pharmaceuticals
- Indication
- Asthma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed